Denosumab-Induced Osteonecrosis of the Jaw with FDG PET/CT imaging features.
Denosumab is a monoclonal antibody that inhibits receptor activator of nuclear factor-kappa B ligand (RANKL), which plays a crucial role in osteoclast formation, function, and survival. By blocking RANKL, denosumab helps prevent bone resorption, making it an effective therapeutic option for managin...
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Makale |
| Dil: | English |
| Baskı/Yayın Bilgisi: |
SJORANM GmbH (Ltd.)
2024-11-01
|
| Seri Bilgileri: | Swiss Journal of Radiology and Nuclear Medicine |
| Konular: | |
| Online Erişim: | https://sjoranm.com/sjoranm/article/view/47 |